Log in to save to my catalogue

Anti‐ BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependen...

Anti‐ BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2290033530

Anti‐ BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependent and Fc‐independent mechanisms

About this item

Full title

Anti‐ BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependent and Fc‐independent mechanisms

Publisher

Frankfurt: EMBO Press

Journal title

EMBO molecular medicine, 2015-04, Vol.7 (4), p.464-476

Language

English

Formats

Publication information

Publisher

Frankfurt: EMBO Press

More information

Scope and Contents

Contents

Type I interferons (IFN‐I) are implicated in the pathogenesis of systemic lupus erythematosus (SLE). In SLE, immune complexes bind to the CD32a (FcγRIIa) receptor on the surface of plasmacytoid dendritic cells (pDCs) and stimulate the secretion of IFN‐I from pDCs. BDCA2 is a pDC‐specific receptor that, when engaged, inhibits the production of IFN‐I...

Alternative Titles

Full title

Anti‐ BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependent and Fc‐independent mechanisms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2290033530

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2290033530

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201404719

How to access this item